- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06616064
Evaluation of a Procedure for Identification and Brief Intervention of Lifestyle Advice Assisted by Application in a Care Setting (CliniCAP)
May 20, 2025 updated by: Rennes University Hospital
Chronic diseases share similar risk factors associated with four daily behaviours: unbalanced diet, sedentary lifestyle (physical inactivity and time spent sitting down), smoking and alcohol consumption.
These diseases are responsible for 74% of deaths worldwide.
Despite the frequency with which practitioners witness these bad habits in their patients, little time is devoted to lifestyle advice during medical visits, and even less to using effective techniques to discuss their behaviour.
Yet medical and paramedical consultations could be an essential educational opportunity to promote a healthy lifestyle.
But advice is often limited during medical check-ups, due to a lack of time and suitable tools, and is often focused on a particular risk factor.
To date, there is no procedure for screening and behavioural intervention to deal with harmful lifestyle habits in patients.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Interventional
Enrollment (Actual)
164
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rennes cedex 9, France, 35033
- CHU Rennes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥ 18 years
- Treated for a stabilised chronic disease OR person treated for localised cancer, after the end of heavy treatment during the follow-up period within 5 years of the date of diagnosis of the cancer.
- Contactable by telephone
- Affiliated to a social security scheme
- Having signed a free, informed and written consent.
Exclusion Criteria:
- Requiring psychiatric assessment
- Suffering from eating disorders
- Undergoing dietetic treatment or therapeutic education for dietetic purposes (at least two consultations at the same facility in the previous year)
- Suffering from a life-threatening condition within 5 years
- Suffering from a disabling condition (reduced activity with major restrictions)
- Unable to read
- Taking part in another psycho-behavioural nutritional intervention study
- Protected person (adult subject to legal protection (safeguard of justice, curatorship, guardianship), person deprived of liberty, pregnant woman (declaratory), breast-feeding woman and minor).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
|
personalised feedback and brief motivational
routine lifestyle advice
questionnaire CliniCAP
|
|
Other: Control
|
routine lifestyle advice
questionnaire CliniCAP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of green criteria on application feedback
Time Frame: between Day 0 and Month 1
|
The green criterioa corresponds to good compliance with health recommendations.
|
between Day 0 and Month 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Romain Moirand, CHU Rennes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 21, 2024
Primary Completion (Estimated)
July 1, 2025
Study Completion (Estimated)
October 1, 2025
Study Registration Dates
First Submitted
September 20, 2024
First Submitted That Met QC Criteria
September 24, 2024
First Posted (Actual)
September 27, 2024
Study Record Updates
Last Update Posted (Actual)
May 21, 2025
Last Update Submitted That Met QC Criteria
May 20, 2025
Last Verified
September 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35RC23_9738_CliniCAP
- 2024-A01631-46 (Other Identifier: N°ID-RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of LimerickCompletedChronic Conditions, MultipleIreland
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on personalised feedback and brief motivational
-
University of BathRecruitingPlant Food IntakeUnited Kingdom
-
King's College LondonCompleted
-
Brown UniversityNational Institute of General Medical Sciences (NIGMS)CompletedSteatotic Liver Disease of Mixed Origin (MetALD)United States
-
The University of Hong KongCompletedWomen at Risk of Common Mental DisordersHong Kong
-
Brown UniversityRhode Island Hospital; National Institute of General Medical Sciences (NIGMS)Active, not recruitingLiver Diseases | Alcohol Use DisorderUnited States
-
St. Jude Children's Research HospitalNot yet recruitingSubstance Use | Survivors of Childhood CancerUnited States
-
Imperial College LondonActive, not recruitingFrailty | Feasibility Studies | Older Adults (65 Years and Older) | Digital Health InterventionUnited Kingdom
-
Connecticut Children's Medical CenterCommunity Health NetworkCompleted
-
Centers for Disease Control and PreventionWithdrawnAccidents, Traffic
-
University of California, San DiegoUniversity of Southern California; Lundquist Institute for Biomedical Innovation... and other collaboratorsCompletedHIV Seronegativity | Patient AdherenceUnited States